Clinical Trial Update: AN0025 and Chemoradiotherapy Combination in Esophageal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AN0025 in combination with chemoradiotherapy for esophageal cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• AN0025

Snippet

Sponsor: Adlai Nortye Biopharma Co., Ltd. | Conditions: Esophageal Cancer | Phase 1 | Status: SUSPENDED